1. FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma. (26th March 2019) Authors: Richardson, Nicholas C.; Kasamon, Yvette L.; Chen, Haiyan; de Claro, R. Angelo; Ye, Jingjing; Blumenthal, Gideon M.; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 24:Number 5(2019) Page Start: e180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy. (13th September 2017) Authors: Bhatnagar, Vishal; Gormley, Nicole J.; Luo, Lola; Shen, Yuan Li; Sridhara, Rajeshwari; Subramaniam, Sriram; Shen, Guoxiang; Ma, Lian; Shord, Stacy; Goldberg, Kirsten B.; Farrell, Ann T.; McKee, Amy E.; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 11(2017) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma. (7th February 2018) Authors: Pulte, Elizabeth Dianne; Dmytrijuk, Andrew; Nie, Lei; Goldberg, Kirsten B.; McKee, Amy E.; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis. (16th August 2018) Authors: Kasamon, Yvette L.; Ko, Chia‐Wen; Subramaniam, Sriram; Ma, Lian; Yang, Yuching; Nie, Lei; Shord, Stacy; Przepiorka, Donna; Farrell, Ann T.; McKee, Amy E.; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 12(2018) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia. (12th April 2018) Authors: Norsworthy, Kelly J.; Ko, Chia‐Wen; Lee, Jee Eun; Liu, Jiang; John, Christy S.; Przepiorka, Donna; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 9(2018) Page Start: 1103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma. (24th April 2017) Authors: Kasamon, Yvette L.; de Claro, R. Angelo; Wang, Yaping; Shen, Yuan Li; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 5(2017) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma. (May 2017) Authors: Kasamon, Yvette L.; de Claro, R. Angelo; Wang, Yaping; Shen, Yuan Li; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 22:Number 5(2017) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome. (6th April 2018) Authors: Le, Robert Q.; Li, Liang; Yuan, Weishi; Shord, Stacy S.; Nie, Lei; Habtemariam, Bahru A.; Przepiorka, Donna; Farrell, Ann T.; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 8(2018) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia. (17th July 2018) Authors: Pulte, E. Dianne; Vallejo, Jonathon; Przepiorka, Donna; Nie, Lei; Farrell, Ann T.; Goldberg, Kirsten B.; McKee, Amy E.; Pazdur, Richard Journal: Oncologist Issue: Volume 23:Number 11(2018) Page Start: 1366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation. (September 2020) Authors: Kanapuru, Bindu; Singh, Harpreet; Kwitkowski, Virginia; Blumenthal, Gideon; Farrell, Ann T.; Pazdur, Richard Journal: Blood reviews Issue: Volume 43(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗